缬沙坦与厄贝沙坦治疗老年高血压合并室性心律失常的疗效分析

Efficacy of valsartan or irbesartan in treatment of elderly hypertensive patients with ventricular arrhythmia

目的分析老年高血压合并室性心律失常患者行缬沙坦、厄贝沙坦疗法的效果。方法从我院2012年6月-2015年5月随机抽选行缬沙坦疗法的60例高血压合并室性心律失常患者作为对象,并将同期收治的行厄贝沙坦疗法的60例患者作为实验组,评定治疗后的效果。结果对照组、实验组患者经由不同药物治疗后,血压指标(收缩压、舒张压)明显性变化,两组统计有差异,P<0.05。结论临床于老年高血压合并室性心律失常治疗中实施厄贝沙坦疗法效果突出,不但可缓解患者的症状,还可预防室性心律失常病症的发生,增强总体效果,值得借鉴。

Objective To investigate the efficacy of valsartan or irbesartan in the treatment of elderly hypertensive patients with ventricular arrhythmia. Methods A total of 60 hypertensive patients with ventricular arrhythmia who were treated with valsartan in our hospital from June 2012 to May 2015 were randomly selected as study subjects, and another 60 patients who were admitted during the same period of time and treated with irbesartan were enrolled as experimental group. Efficacy was compared between the two groups. Results The blood pressure parameters（systolic pressure and diastolic pressure） showed significant changes after treatment with different drugs and showed significant differences between the two groups（P〈0.05）. Conclusion Irbesartan treatment has good efficacy in the treatment of elderly hypertensive patients with ventricular arrhythmia. It can alleviate the patients＇ symptoms, prevent the development of ventricular arrhythmia, and enhance overall response, and therefore, it holds promise for clinical application.